Riboflavin-UVA-Crosslinking beim Keratokonus
Authors:
- 14 June 2013
- journal article
- abstracts
- Published by Springer Nature in Der Ophthalmologe
- Vol. 110 (9) , 818-822
Abstract
Keratoconus is a progressive, ectatic disease of the cornea leading to thinning and highly irregular astigmatism. Until recently all treatment options, such as prescription of glasses or contact lenses were symptomatic and neither keratoplasty nor the implantation of intracorneal rings can heal the disease. Riboflavin ultraviolet A (UVA) collagen cross-linking (CXL) cannot heal keratoconus either but promises to halt the progression. The therapeutic principle is a photochemical reaction of riboflavin and UVA light leading to free oxygen radicals in the corneal stroma that induce covalent linking of the collagen fibrils. This stiffening effect should stop the progression. After the first reports at the end of the 1990s the treatment was widely used and many case series show that CXL can be effective in stopping disease progression in some patients. However, randomized, controlled multicenter trials showing high evidence of the treatment effectiveness are rare. This report includes a review of the literature regarding treatment effectiveness, indications and new developments.Keywords
This publication has 32 references indexed in Scilit:
- Intraoperative Corneal Thickness Measurements During Corneal Collagen Cross-Linking With Hypoosmolar Riboflavin Solution in Thin CorneasCornea, 2012
- Transepithelial corneal collagen crosslinking: Bilateral studyJournal of Cataract & Refractive Surgery, 2012
- Long term results of a prospective randomized bilateral eye comparison trial of higher fluence, shorter duration ultraviolet A radiation, and riboflavin collagen cross linking for progressive keratoconusClinical Ophthalmology, 2012
- Corneal Collagen Cross-linking With Riboflavin and Ultraviolet-A Irradiation in Patients With Thin CorneasAmerican Journal of Ophthalmology, 2012
- Limbal and Conjunctival Epithelium After Corneal Cross-linking Using Riboflavin and UVACornea, 2011
- Transient Corneal Thinning in Eyes Undergoing Corneal Cross-LinkingAmerican Journal of Ophthalmology, 2011
- Age-Related Long-Term Functional Results after Riboflavin UV A Corneal Cross-LinkingJournal of Ophthalmology, 2011
- Corneal Cross-linking with Hypo-osmolar Riboflavin Solution in Thin Keratoconic CorneasAmerican Journal of Ophthalmology, 2011
- Transepithelial Corneal Collagen Cross-Linking in KeratoconusJournal of Refractive Surgery, 2010
- Long-Term Graft Survival in Penetrating Keratoplasty: The Biexponential Model of Chronic Endothelial Cell Loss RevisitedCornea, 2010